Process monitoring of an HIV treatment as prevention program in British Columbia, Canada

scientific article

Process monitoring of an HIV treatment as prevention program in British Columbia, Canada is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/QAI.0000000000000293
P932PMC publication ID4257704
P698PubMed publication ID25072608

P50authorJulio MontanerQ1712378
Mel KrajdenQ6810759
Robert S HoggQ37837778
Michelle MurtiQ60313150
Neora PickQ87794641
Rolando BarriosQ90107064
Bohdan NosykQ90801622
Melanie L A RuschQ114738817
Guillaume ColleyQ114776788
Reka GustafsonQ117254132
STOP HIV/AIDS Study GroupQ117254133
Stephanie KonradQ125344604
Theodora ConsolacionQ125344608
P2093author name stringViviane D Lima
Mark Gilbert
Irene Day
James Haggerstone
Jennifer May-Hadford
Joanne Nelson
Kate Heath
Lillian Lourenço
P2860cites workLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesQ24597052
Prevention of HIV-1 infection with early antiretroviral therapyQ24634688
Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health ApproachQ26859055
Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, CanadaQ28474271
Development and validation of a composite programmatic assessment tool for HIV therapyQ28485260
Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, CanadaQ28485334
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaQ28537704
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian settingQ28539721
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050Q28732123
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelQ29305377
Explaining health care expenditure variation: large-sample evidence using linked survey and health administrative data.Q30598968
Linking Canadian population health data: maximizing the potential of cohort and administrative dataQ30653140
The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort studyQ33598342
Decreases in community viral load are accompanied by reductions in new HIV infections in San FranciscoQ33604727
Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC)Q34001233
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based studyQ34126545
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.Q34289633
Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in TaiwanQ34338902
The burden of community-acquired pneumonia in seniors: results of a population-based studyQ34373295
Disparities in the burden of HIV/AIDS in CanadaQ34499532
Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort studyQ34645964
Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery systemQ35019905
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infectionQ35019915
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over timeQ36712393
"Taking a half day at a time:" patient perspectives and the HIV engagement in care continuumQ36865816
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.Q37175647
Cost-effectiveness of HIV treatment as prevention in serodiscordant couplesQ37554064
A national review of vertical HIV transmissionQ37972584
The state of engagement in HIV care in the United States: from cascade to continuum to controlQ38116750
The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realitiesQ38150179
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.Q41002448
A side door into care cascade for HIV-infected patients?Q42258378
Engaging HIV-infected patients in care: their lives depend on it.Q43492511
Expanding access to HAART: a cost-effective approach for treating and preventing HIV.Q45183580
Differential impact of adherence on long-term treatment response among naive HIV-infected individualsQ57259643
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts ≥ 200 cells/μlQ57259705
Factors associated with use of HIV primary care among persons recently diagnosed with HIV: Examination of variables from the behavioural model of health-care utilizationQ58269233
Framework for program evaluation in public healthQ73025047
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapyQ77230682
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectCanadaQ16
prevention of HIV/AIDSQ7242372
P304page(s)e94-e109
P577publication date2014-11-01
P1433published inJournal of Acquired Immune Deficiency SyndromesQ6294722
P1476titleProcess monitoring of an HIV treatment as prevention program in British Columbia, Canada
P478volume67

Reverse relations

cites work (P2860)
Q61807821"Condoms are … like public transit. It's something you want everyone else to take": Perceptions and use of condoms among HIV negative gay men in Vancouver, Canada in the era of biomedical and seroadaptive prevention
Q41993740A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015
Q35171945AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study
Q39539551Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada
Q49939556Gay Men's Understanding and Education of New HIV Prevention Technologies in Vancouver, Canada
Q35947588Gay and bisexual men's awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada
Q93083038Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
Q98947365Implementation opportunities and challenges identified by key stakeholders in scaling up HIV Treatment as Prevention in British Columbia, Canada: a qualitative study
Q39407573Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting
Q38703295Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS.
Q36995586Pre-exposure Prophylaxis Awareness Among Gay and Other Men who have Sex with Men in Vancouver, British Columbia, Canada
Q36744865Sexual and reproductive health and human rights of women living with HIV.
Q36353816Sexual inactivity and sexual satisfaction among women living with HIV in Canada in the context of growing social, legal and public health surveillance
Q36322539Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study

Search more.